Healthcare Realty Trust Incorporated (HR)

NYSE: HR · USD

$17.5

-0.40 (-2.3%)· Recorded snapshot

Market cap	6.1B
Revenue (ttm)	1.1B
Net income (ttm)	-89.6M
EPS (ttm)	-$0.26
Shares out	347M
P/E (forward)	360.8x
Dividend	$0.96 (5.49%)
Volume	4,824,510
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -89.6M
EPS (ttm): -$0.26
P/E (forward): 360.8x
Market cap: 6.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	Verminderen
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	Aanhouden
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	Verkopen

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E360.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1.9

P25 n/aP50 n/aP75 n/a

ROIC0.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HR indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001360604
Company name	Healthcare Realty Trust Incorporated
Country	United States
Country code	US
CUSIP number	42226K105
Earnings date	2026-10-29
Earnings time	amc
Employees	539
Employees change	-11
Employees growth	-2%
Enterprise value	$10.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1992
Industry	REIT - Healthcare Facilities
IPO date	1993-05-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US42226K1051
Last 10-K release date	2026-02-13
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.1B
Market cap category	Mid-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$17.49
Price currency	USD
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-28
Symbol	HR
U.S. state	Tennessee
Website	https://www.healthcarerealty.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	102.76x
Earnings yield	-1.49%
EV/EBIT	78.73x
EV/EBITDA	14.86x
EV/FCF	84.25x
EV/Sales	9.08x
FCF / EV yield	1.19%
FCF yield	2.05%
Forward EV/Sales	9.2x
Forward P/E	360.82x
Forward P/S	5.33x
Industry forward P/E	67.9x
Industry P/E	80.05x
P/(FCF - SBC) ratio	58.52x
P/(OCF - SBC) ratio	14.36x
P/B ratio	1.45x
P/FCF ratio	48.86x
P/FFO ratio	12.38x
P/OCF ratio	13.7x
P/S ratio	5.26x
Price / tangible book value	1.43x
Price/EBITDA ratio	8.62x
Sector forward P/E	30.05x
Sector P/E	41.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.53%
EBITDA margin	61.09%
FCF margin	10.77%
Gross margin	61.95%
Operating margin	11.53%
Pretax margin	-7.66%
Profit margin	-7.57%
Profit per employee	$-166,319
Revenue per employee	$2.1M
ROA	0.86%
ROA (5Y)	0.56%
ROCE	1.55%
ROE	-1.92%
ROE (5Y)	-3.13%
ROIC	0.89%
SBC / revenue	1.78%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
Net income growth quarters	4
Net income growth years	1
OCF growth	-5.8%
OCF growth (Q)	-12.88%
OCF growth (QoQ)	168.9%
OCF growth 10Y	11.24%
OCF growth 3Y	2.23%
OCF growth 5Y	-1.28%
Revenue growth	-6.08%
Revenue growth (Q)	-4.33%
Revenue growth (QoQ)	1.89%
Revenue growth 10Y	11.18%
Revenue growth 3Y	-4.42%
Revenue growth 5Y	17.53%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-306.3M
Depreciation and amortization	$511.5M
EBIT	$132.4M
EBITDA	$701.3M
EPS	$-0.26
FCF per share	$0.36
Financing cash flow	$-1.1B
Free cash flow	$123.7M
Free cash flow minus SBC	$103.2M
Funds from operations (FFO)	$495.7M
Gross profit	$711.1M
Investing cash flow	$700.4M
Net cash flow	$-6.7M
Net income	$-89.6M
Operating cash flow minus SBC	$420.7M
Operating income	$132.4M
Revenue	$1.1B
Stock-based compensation	$20.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$12.30
Debt / EBITDA	6.08
Debt / equity	1.03
Debt / FCF	35.6
Interest coverage	0.68
Net cash (debt)	$-4.4B
Net cash / market cap	-72.45%
Net debt / EBITDA	6.24
Net debt / equity	1.02
Net debt / FCF	35.4
Piotroski F-Score	4
Property, plant and equipment	$7.9B
Shareholders' equity	$4.3B
Tangible book value	$4.2B
Tangible book value per share	$12.30
Total assets	$9B
Total cash	$24.7M
Total debt	$4.4B
Total liabilities	$4.7B
WACC	6.58%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.12
Current ratio	0.34
Net working capital	$-34.8M
Quick ratio	0.05
Working capital	$-314.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.41%
Dividend growth	-17.95%
Dividend growth (10Y)	-2.21%
Dividend growth (3Y)	-8.18%
Dividend growth (5Y)	-4.48%
Dividend growth years	0
Dividend payment date	2026-08-26
Dividend payment years	34
Dividend payout frequency	Quarterly
Dividend per share	$0.96
Dividend yield	5.49%
Ex-dividend date	2026-08-11
FCF payout ratio	269.32%
Last dividend	$0.24
Shareholder yield	6.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-44.91%
10Y return CAGR	-0.88%
10Y total return	-8.44%
150-day SMA	$19.22
15Y price change	-8.72%
15Y return CAGR	4.5%
15Y total return	93.44%
1D price change	-2.26%
1M price change	-3.71%
1M total return	-3.71%
1W price change	-2.14%
1W total return	-2.14%
1Y price change	-6.91%
1Y return CAGR	-2.07%
1Y total return	-2.07%
20-day SMA	$17.40
200-day SMA	$18.82
20Y price change	-57.14%
20Y return CAGR	1.85%
20Y total return	44.37%
3M price change	-19.28%
3M total return	-18.28%
3Y price change	23%
3Y return CAGR	14.67%
3Y total return	50.81%
50-day SMA	$18.21
50-day SMA vs 200-day SMA	50under200
52-week high	$22.04
52-week high date	2026-07-29
52-week low	$16.31
52-week low date	2026-01-29
5Y price change	-47.79%
5Y return CAGR	-6.56%
5Y total return	-28.78%
6M price change	-5.44%
6M total return	-3.12%
All-time high	$44.19
All-time high date	2007-02-08
All-time low	$12.06
All-time low date	2009-03-06
Average true range (ATR)	$0.39
Average volume	5.3M
Beta (1Y)	0.2
Beta (2Y)	0.21
Beta (5Y)	0.84
Change from 52-week high	-20.67%
Change from 52-week low	7.2%
Change from all-time high	-60.67%
Change from all-time low	44.11%
Change from open	-1.21%
Day's gap	-1.06%
Dollar volume	$84.4M
High price	$17.70
Low price	$17.34
Monthly RSI	47.13
Open price	$17.70
Position in 52-week range	40.28%
Previous close	$17.89
Price vs 150-day SMA	-9.55%
Price vs 20-day SMA	-0.09%
Price vs 200-day SMA	-7.66%
Price vs 50-day SMA	-4.57%
Relative volume	0.91
RSI	43.68
Sharpe ratio	-0.21
Sharpe ratio (3Y)	0.51
Sharpe ratio (5Y)	-0.28
Sortino ratio	-0.01
Sortino ratio (3Y)	1
Sortino ratio (5Y)	-0.18
Volume	4.8M
Weekly RSI	38.43
YTD price change	2.54%
YTD total return	6.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	340.4M
Float percentage	98.1%
Shares change (QoQ)	-1.48%
Shares change (YoY)	-1.41%
Shares held by insiders	0.59%
Shares held by institutions	111.75%
Shares outstanding	347M
Short % of float	5.52%
Short % of shares	5.42%
Short ratio	4.6 days

Deeper analysis on HR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Frequently asked questions

About this HR report

Is a complete HR research report available?

No complete published report is available for Healthcare Realty Trust Incorporated (HR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Healthcare Realty Trust Incorporated (HR)

Price

Financial snapshot

Fair-value bridge

Latest news · HR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HR

Frequently asked questions